Bone marrow stromal cells induced activation of nuclear factor κB signaling protects non-Hodgkin's B lymphoma cells from apoptosis.

scientific article published on 12 February 2016

Bone marrow stromal cells induced activation of nuclear factor κB signaling protects non-Hodgkin's B lymphoma cells from apoptosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S13277-016-4860-1
P698PubMed publication ID26873486

P2093author name stringHong Jiang
Lei Pan
Wei Han
Sheng Zhao
Yali Xu
Jin Qian
Lixin Sun
Jiakai Li
Xiaorong Ma
Xiaobin Li
Xinying Xue
Zuojun Liu
Xinmin Ding
Mingming Meng
Tuo Su
P2860cites workTNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomasQ38352213
Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosisQ39931092
Oncogenic CARD11 mutations in human diffuse large B cell lymphomaQ40005246
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cellsQ40137818
Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinaseQ40954925
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphomaQ41815132
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adultsQ42597179
BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.Q53664665
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune CellsQ57279527
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytesQ24338639
RANK is essential for osteoclast and lymph node developmentQ24598872
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaQ24613755
Initial genome sequencing and analysis of multiple myelomaQ24629117
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphomaQ24676965
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingQ27860529
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathwayQ28214369
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myelomaQ28250998
Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphomaQ28256118
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomasQ28292747
Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activationQ29617419
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphomaQ33432504
Cellular origin of human B-cell lymphomas.Q33772424
The noncanonical NF-κB pathwayQ34031207
Pathogenesis of human B cell lymphomasQ34245261
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.Q34277639
Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphomaQ34407534
Frequent inactivation of A20 in B-cell lymphomasQ34607223
Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).Q34983966
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsQ35029409
Proteases, extracellular matrix, and cancer: a workshop of the path B study sectionQ35097428
Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomasQ35989467
Mechanisms of B-cell lymphoma pathogenesisQ36085626
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferationQ36362226
Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune responseQ36368953
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitectureQ36400143
The biology of Hodgkin's lymphomaQ37349652
The microenvironment in mature B-cell malignancies: a target for new treatment strategiesQ37563816
BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesisQ37761495
P433issue8
P304page(s)10745-10752
P577publication date2016-02-12
P1433published inTumor BiologyQ15757842
P1476titleBone marrow stromal cells induced activation of nuclear factor κB signaling protects non-Hodgkin's B lymphoma cells from apoptosis.
P478volume37

Reverse relations

cites work (P2860)
Q47669883BAFF is involved in macrophage-induced bortezomib resistance in myeloma.
Q38889427Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.
Q64239856Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels
Q41200607The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy.